http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2699558-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C335-24
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C335-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
filingDate 2018-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e04d927934379cac8b02479ed2d3af7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e6ad406839dc4b41f94576761fa2b337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d77b8f7f57fadbfa87307c7d928e7b3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ce8bb6665e251b9f9c35bb90fa92e09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccfdb80b9264113cb6ebc91d3009acfd
publicationDate 2019-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2699558-C2
titleOfInvention Agent for targeted therapy of malignant growths
abstract FIELD: chemistry. n SUBSTANCE: invention relates to 1-isobutanoyl-2-isopropyl isothiourea dichloroacetate (compound T1084) with the structural formula: n n n n as a target therapeutic agent for solid malignant growths, having a complex anti-non-regional action – NOS-inhibiting anti-angiogenic and PDK1-inhibiting hypoxia-oriented cytotoxic. n EFFECT: providing effective and stable anti-tumor action and inhibiting (or inhibiting) development of tumor resistance to anti-angiogenic therapy, as well as broader capabilities for developing new pharmacological agents for complex targeted therapy of oncological diseases. n 5 cl, 1 dwg, 3 tbl, 5 ex
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2804771-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2733883-C2
priorityDate 2018-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9509619-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-94020614-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2034543-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2503450-C1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25975
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545070
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP45639
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID413367480
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11167602
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139599833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440667
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452881501
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ02454
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13487
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3555130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474833
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419542324

Total number of triples: 43.